Lysophosphatidic acid interacts with transforming growth factor-β signaling to mediate keratinocyte growth arrest and chemotaxis

Journal of Investigative Dermatology

Volumn 123, Issue 5, 2004, Pages 840-849

  Sauer, Bettina ^a   Vogler, Rüdiger ^a   Zimmermann, Karsten ^a   Fujii, Makiko ^b   Anzano, Mario B ^b   Schäfer Korting, Monika ^a   Roberts, Anita B ^b   Kleuser, Burkhard ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Lipid mediators; Migration; Proliferation; Smad3 protein

Indexed keywords

CYTOKINE; DNA; LYSOPHOSPHATIDIC ACID; SMAD3 PROTEIN; SMAD4 PROTEIN; THROMBIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER INVASION; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; DEGRANULATION; EPIDERMIS CELL; GROWTH INHIBITION; HETEROMERIZATION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN POLYMERIZATION; SIGNAL TRANSDUCTION; SKIN INJURY; THROMBOCYTE; WOUND CLOSURE;

EID: 6344272396     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.23458.x     Document Type: Article

References (51)

1. Alexandrow MG, Moses HL: Transforming growth factor beta 1 inhibits mouse keratinocytes late in G1 independent of effects on gene transcription. Cancer Res 55:3928-3932, 1995
2. Aoki J, Taira A, Takanezawa Y, et al: Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 277:48737-48744, 2002
3. Ashcroft GS, Roberts AB: Loss of Smad3 modulates wound healing. Cytokine Growth Factor Rev 11:125-131, 2000
4. Ashcroft GS, Yang X, Click AB, et al: Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1:260-266, 1999
5. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, Parsons SJ: c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem 274:8335-8343, 1999
6. Brown KD: The epidermal growth factor/transforming growth factor-alpha family and their receptors. Eur J Gastroenterol Hepatol 7:914-922, 1995
7. Bunce CM, Thick JA, Lord JM, Mills D, Brown G: A rapid procedure for isolating hemopoietic cell nuclei. Anal Biochem 175:67-73, 1988
8. Contos JJ, Ishii I, Chun J: Lysophosphatidic acid receptors. Mol Pharmacol 58:1188-1196, 2000
9. de Caestecker MP, Parks WT, Frank CJ, Castagnino P, Bottaro DP, Roberts AB, Lechleider RJ: Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev 12:1587-1592, 1998
10. Dignass AU, Podolsky DK: Cytokine modulation of intestinal epithelial cell restitution: Central role of transforming growth factor beta. Gastroenterology 105:1323-1332, 1993
11. Fanayan S, Firth SM, Baxter RC: Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling. J Biol Chem 277:7255-7261, 2002
12. Fanayan S, Firth SM, Butt AJ, Baxter RC: Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta) and the type II TGF-beta receptor. J Biol Chem 275:39146-39151, 2000
13. Firth SM, Baxter RC: Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854, 2002
14. Fujimoto A, Fluharty AL, Stevens RL, Kihara H, Wilson MG: Two alpha-glucosidases in cultured amniotic fluid cells and their differentiation in the prenatal diagnosis of Pompe's disease. Clin Chim Acta 68:177-186, 1976
15. Gaits F, Fourcade O, Le Balle F, et al: Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis. FEBS Lett 410:54-58, 1997
16. Herrlich A, Daub H, Knebel A, Herrlich P, Ullrich A, Schultz G, Gudermann T: Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells. Proc Natl Acad Sci USA 95:8985-8990, 1998
17. Hordijk PL, Verlaan I, van Corven EJ, Moolenaar WH: Protein tyrosine phosphorylation induced by lysophosphatidic acid in Rat-1 fibroblasts. Evidence that phosphorylation of map kinase is mediated by the Gi-p21ras pathway. J Biol Chem 269:645-651, 1994
18. Huang MC, Graeler M, Shankar G, Spencer J, Goetzl EJ: Lysophospholipid mediators of immunity and neoplasia. Biochim Biophys Acta 1582:161-167, 2002
19. Kim J, Ahn S, Quo R, Daaka Y: Regulation of epidermal growth factor receptor internalization by G protein-coupled receptors. Biochemistry 42:2887-2894, 2003
20. Laping NJ, Grygielko E, Mathur A, et al: Inhibition of Transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB431542. Mol Pharmacol 62:58-64, 2002
21. Lee H, Goetzl EJ, An S: Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol Cell Physiol 278: C612-C618, 2002
22. Lee SJ: Cytokine delivery and tissue engineering. Yonsei Med J 41:704-719, 2002
23. Massague J: TGF-beta signal transduction. Annu Rev Biochem 67:753-791, 1998
24. Massague J: How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1:169-178, 2000
25. Massague J, Chen YG: Controlling TGF-beta signaling. Genes Dev 14:627-644, 2000
26. Massague J, Wotton D: Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19:1745-1754, 2000
27. McIntyre TM, Pontsler AV, Suva AR, et al: Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc Natl Acad Sci USA 100:131-136, 2003
28. Mills GB, Eder A, Fang X, et al: Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer. Cancer Treat Res 107:259-283, 2002
29. Moolenaar WH: Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res 253:230-238, 1999
30. Moolenaar WH: Development of our current understanding of bioactive lysophospholipids. Ann NY Acad Sci 905:1-10, 2000
31. Moolenaar WH, Kranenburg O, Postma FR, Zondag GC: Lysophosphatidic acid: G-protein signalling and cellular responses. Curr Opin Cell Biol 9:168-173, 1997
32. Nishihara A, Hanai J, Imamura T, Miyazono K, Kawabata M: E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins. J Biol Chem 274:28716-28723, 1999
33. O'Kane S, Ferguson MW: Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 29:63-78, 1997
34. Osborne N, Stainier DY: Lipid receptors in cardiovascular development. Annu Rev Physiol 65:23-43, 2003
35. Pages G, Girard A, Jeanneton O, et al: LPA as a paracrine mediator of adipocyte growth and function. Ann NY Acad Sci 905:159-164, 2000
36. Panetti TS, Magnusson MK, Peyruchaud O, Zhang Q, Cooke ME, Sakai T, Mosher DF: Modulation of cell interactions with extracellular matrix by lysophosphatidic acid and sphingosine 1-phosphate. Prostaglandins 64: 93-106, 2001
37. Piazza GA, Ritter JL, Baracka CA: Lysophosphatidic acid induction of transforming growth factors alpha and beta: Modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Exp Cell Res 216:51-64, 1995
38. Roberts AB, Flanders KC, Heine UI, et al: Transforming growth factor-beta: Multifunctional regulator of differentiation and development. Philos Trans R Soc Lond B Biol Sci 327:145-154, 1990
39. Roberts AB, Sporn MB: Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 8:1-9, 1993
40. Sano T, Baker D, Virag T, et al: Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. J Biol Chem 277:21197-21206, 2002
41. Shida D, Kitayama J, Yamaguchi H, et al: Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res 63:1706-1711, 2003
42. Sturm A, Sudermann T, Schulte KM, Goebell H, Dignass AU: Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid. Gastroenterology 117:368-377, 1999
43. Suemori S, Ciacci C, Podolsky DK: Regulation of transforming growth factor expression in rat intestinal epithelial cell lines. J Clin Invest 87:2216-2221, 1991
44. Takuwa Y, Takuwa N, Sugimoto N: The Edg family G protein-coupled receptors for lysophospholipids: Their signaling properties and biological activities. J Biochem (Tokyo) 131:767-771, 2002
45. Tigyi G, Dyer DL, Miledi R: Lysophosphatidic acid possesses dual action in cell proliferation. Proc Natl Acad Sci USA 91:1908-1912, 1994
46. Tokumura A, Iimori M, Nishioka Y, Kitahara M, Sakashita M, Tanaka S: Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol 267:204-210, 1994
47. Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL: SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 95:779-791, 1998
48. Vogler R, Sauer B, Kim DS, Schäfer-Korting M, Kleuser B.: Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healing. J Invest Dermatol 120:693-700, 2003
49. Wang F, Nohara K, Olivera A, Thompson EW, Spiegel S: Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate. Exp Cell Res 247:17-28, 1999
50. Yan Y, Shirakabe K, Werb Z: The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol 158:221-226, 2002
51. Yang X, Letterio JJ, Lechleider RJ, et al: Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished Tcell responsiveness to TGF-beta. EMBO J 18:1280-1291, 1999